Clinical Trial Update: Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating aldosterone and the mineralocorticoid receptor in cardiovascular disease for individuals with metabolic syndrome, hypertension, and ove…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypertension
• Metabolic Syndrome
• Obesity

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Metabolic Syndrome, Hypertension | Phase 4 | Status: COMPLETED